Cargando…
Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody
BACKGROUND: The search for strategies to target ion channels for therapeutic applications has become of increasing interest. Especially, the potassium channel K(V)10.1 (Ether-á-go-go) is attractive as target since this surface protein is virtually not detected in normal tissue outside the central ne...
Autores principales: | Hartung, Franziska, Stühmer, Walter, Pardo, Luis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179451/ https://www.ncbi.nlm.nih.gov/pubmed/21899742 http://dx.doi.org/10.1186/1476-4598-10-109 |
Ejemplares similares
-
In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K(v)10.1
por: Napp, Joanna, et al.
Publicado: (2016) -
A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells
por: Hartung, Franziska, et al.
Publicado: (2020) -
Rapid Internalization of the Oncogenic K(+) Channel K(V)10.1
por: Kohl, Tobias, et al.
Publicado: (2011) -
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
por: Hartung, Franziska, et al.
Publicado: (2016) -
Functional K(V)10.1 Channels Localize to the Inner Nuclear Membrane
por: Chen, Ye, et al.
Publicado: (2011)